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Abstract
The epidemiology of dengue is characterised by irregular epidemic outbreaks and desynchronised dynamics of its four co-
circulating virus serotypes. Whilst infection by one serotype appears to convey life-long protection to homologous
infection, it is believed to be a risk factor for severe disease manifestations upon secondary, heterologous infection due to
the phenomenon of Antibody-Dependent Enhancement (ADE). Subsequent clinical infections are rarely reported and, since
the majority of dengue infections are generally asymptomatic, it is not clear if and to what degree tertiary or quaternary
infections contribute to dengue epidemiology. Here we investigate the effect of third and subsequent infections on the
transmission dynamics of dengue and show that although the qualitative patterns are largely equivalent, the system more
readily exhibits the desynchronised serotype oscillations and multi-annual epidemic outbreaks upon their inclusion. More
importantly, permitting third and fourth infections significantly increases the force of infection without resorting to high
basic reproductive numbers. Realistic age-prevalent patterns and seroconversion rates are therefore easier reconciled with a
low value of dengue’s transmission potential if allowing for more than two infections; this should have important
consequences for dengue control and intervention measures.
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Introduction
Dengue viruses belong to the Flavivirus group of the family
Flaviviridae and today represent a major global concern; transmit-
ted from person to person mainly by the mosquito vector Aedes
aegypti (and to a lesser degree Aedes albopictus) they infect roughly 50
million people every year. Of these, some tens of thousands die
mostly from the more serious disease forms dengue hemorrhagic
fever (DHF) and dengue shock syndrome (DSS). Without
treatment, case-fatality rates for the latter can be as high as
20%, though this drops to around 1% with medical intervention.
The virus itself is organised into four closely related, co-circulating
serotypes: DENV-1, DENV-2, DENV-3 and DENV-4 and long-
term epidemiological data reveal multi-annual cycles in disease
prevalence and sequential replacement of the dominant serotypes
(see Figure 1).
One distinguishing feature of dengue infection is that the risk of
developing DHF and DSS is increased by previous exposure.
Although infection by one serotype results in an individual gaining
complete protective immunity to homologous infection, the
immune response stimulated by this exposure paradoxically
renders the individual much more likely to develop DHF and
DSS upon secondary infection by a heterologous virus. This is
believed to be due to the phenomenon of ‘Antibody-Dependent
Enhancement’ (ADE) whereby sub-neutralising titres of cross-
reactive antibodies promote viral replication [1–3].
The mechanism of ADE and its effect on dengue epidemiology
have been extensively investigated by both clinical studies and
mathematical models (for example [1,3–9]), and it has been
established that there is a competitive advantage for serotypes
conferring ADE. However, there also is a limit on how large the
effect can be before it induces large amplitude oscillations in
serotype incidence that could threaten their continued persistence
[6]. Furthermore, enhancement of either susceptibility to and/or
transmissibility of secondary infection through the action of ADE
seems sufficient to explain the desynchronised serotype dynamics
and observed 3–5 year epidemic cycles [7,9]. However, other
factors such as temporary or clinical cross-protection with or
without seasonal forcing have also been shown to desynchronise
the system into irregular epidemic behaviour [8,10–12], and it is
not yet clear if dengue epidemiology can really be attributed to any
of these factors alone or if it is indeed their combined effect.
A major obstacle in determining the underlying nature of
dengue epidemiology lies in the fact that most data are based on
clinically reported cases. However, it is widely recognised that a
high proportion of dengue infections are asymptomatic and
clinically imperceptible [1,13,14]. For example, a 1996 study in
Haiti demonstrated that over 85% of children had antibodies to
two or more dengue serotypes despite no child having been
hospitalized or dying with clinical symptoms or signs suggestive of
DHF/DSS for at least 16 years [15]. A further complication is a
potential bias in much of the available data towards first and
secondary infection. This is mainly because of the rarity of
clinically observed third and fourth infections [16,17] but also
because of the antibodies’ high cross-reactivity that complicates
the distinction of more than two preceding infections.
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The lack of knowledge in this area is also reflected in the various
theoretical approaches to elucidating dengue’s intriguing epidemi-
ology: whilst some models explicitly include the possibility of third
and fourth infection (e.g. [10,11,18]) others have assumed complete
immunity after a secondary heterologous infection (e.g. [6,9]). In
this paper we explicitly examine the effect of tertiary and quaternary
dengue infections by contrasting the epidemiological dynamics of a
previously analysed ‘twice infected – protected’ model [9] to one
that permits further infections. We show that whilst preserving the
general dynamical behaviour, third and subsequent infections
significantly affect the overall force of infection and the ensuing age-
dependent incidence rates of DHF/DSS in the population.
Methods
We present two models to compare the effect of tertiary and
quaternary infection on the epidemiology and transmission
dynamics of four co-circulating dengue serotypes. The models are
based on previously published epidemiological frameworks [5,6,9]
and differ in their assumptions about acquired immunity. In the first
model we assume that recovery from a secondary heterologous
infection renders the host completely immune against subsequent
challenges. In contrast, the second model assumes that exposure to
all four serotypes is necessary for complete protection. We assume
that after primary infection secondary and subsequent heterologous
infections are enhanced by means of ADE. This case clearly
represents the other extreme end in terms of cross-protection and
enhancement. However, by analysing both extremes it is possible to
interpolate other scenarios where subsequent infections are not
enhanced or even contribute less to dengue transmission.
In a previous study we have demonstrated that increased
transmission and increased susceptibility can both independently
and synergistically explain the desynchronised serotype dynamics
and irregular epidemic outbreaks [9]. For simplicity, we here
assume that enhancement manifests itself solely in terms of
increased onward transmission.
Mathematical models
Within both frameworks we divide the host population into
the following classes: zi denotes the fraction of the population
recovered from infection by at least serotype i; z^i denotes the
fraction of the population recovered from infection by serotype i
only; w denotes the proportion of the population that has
recovered from some form of infection; r is the proportion of the
population completely protected against further infection; s is
the proportion of the population completely susceptible to
infection; yi is the proportion infectious with a primary infection
with strain i; and ~yi is the fraction infectious with serotype i
having previously recovered from infection with a heterologous
serotype.
The first model, where a secondary infection leads to complete
immunity, can then be written as the following set of ordinary
differential equations:
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with the proportion susceptible to any infection simply given as
s~1{r{
P4
i~1
z^i.
The second model, in which immunity is gained only by
exposure to all four serotypes, is given as:
Figure 1. Dengue epidemiology in South Vietnam. The total annual number of dengue cases (blue bars) and relative serotype prevalence
(lines) over the period 1994–2008 in the southern 20 provinces of Viet Nam show the characteristic fluctuation in disease incidence and sequential
replacements of dominant serotypes. Source of data: Vietnamese Ministry of Health Dengue passive surveillance scheme and kindly provided by the
Pasteur Institute, HCMC, Viet Nam. The Hospital for Tropical Diseases is a tertiary referral hospital for infectious diseases.
doi:10.1371/journal.pone.0012347.g001
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In both models, the host population size is assumed to be constant
with 1=m denoting the average host life expectancy and 1=s
representing the average duration of infection. We have assumed
that hosts recover at the same rate from primary and subsequent
infections. Since dengue infection generally lasts less than a week
[19], we assume the incidence of multiple infections to be
negligible.
The force of infection of serotype i, li, is defined as
li~byizwb~yi, where b is the transmission coefficient of
individuals suffering from a first-time dengue infection. w describes
the increase in transmissibility during secondary (or subsequent)
infections due to the action of antibody dependent enhancement
(ADE), with w~1 denoting no enhancement and a value of
w~1:5, for example, corresponding to a 50% increase in
transmissibility.
Although differences in virulence and an effect of infection
order on disease outcome have been suggested, we assume there
are no differences between the serotypes in terms of transmissi-
bility or duration of infection.
In order to compare and contrast the dynamics of our two
models, we performed a series of simulations within the Ro,wð Þ
parameter space, with the basic reproduction number R0 here
defined as b=s. In all cases we varied R0 between 2.5 and 4 solely
through changes in transmissibility b. For simplicity we kept all
other parameter values constant and set m~0:02, equivalent to an
average host life expectancy of 1=m~50 years, and s~73,
equivalent to an infectious period of 1=s~1=73 years or <5 days.
We then explored the effects of both R0 and the level of ADE
within our two models.
Unless stated otherwise, all results and qualitative analyses are
performed after running our models for sufficient time to remove
the effect of transient dynamics and to allow the system to settle
onto a particular dynamical behaviour.
Results
Figure 2 shows the general model output for fixed R0 as a
selection of time series (after removing the transients) and
characterises the wide range of dynamical behaviours observed
in both models under increased levels of enhancement w. In line
with previous studies [5,6,9], the following pattern of behaviour
emerges. For low levels of enhancement we observe a steady-state
equilibrium with all serotypes persisting at equal frequencies. As
the degree of enhancement, w, is increased, the equilibrium is
replaced by synchronized oscillations. Further augmentation of w
desynchronises these oscillations, leading to the emergence of a
Figure 2. General model dynamics under parameter changes. Here we observe the fluctuations in the total proportion of the population that
has been infected by each serotype against time for different levels of transmissibility enhancement w (from left to right: w~1:0, w~1:5, w~2:0,
w~2:5; no enhancement is represented by w~1:0; increasing w corresponds to augmented levels of enhancement). The top panel is for the model
with the assumption of total immunity after two infections only (model (i)) whilst the bottom is for the model which allows for infection with all four
serotypes (model (ii)). The individual serotype dynamics seem to become ever more desynchronised as w increases in both models, though this effect
appears stronger in model (ii).
doi:10.1371/journal.pone.0012347.g002
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more ‘chaotic’ strain structure where individual serotypes are
sequentially replaced. Finally, we approach a state where we detect
periods of low disease prevalence interspersed with semi-regular
epidemic outbreaks. In both models this stage appears to be
further characterised by the sequential replacement of the
dominant serotype.
Notably, however, the time-series presented in Figure 2 suggest
that the progression between these stages is much faster in the
model allowing for third and fourth infections and also suggest that
the amplitude of oscillations in this case is around 5–10 times
larger than in the model where complete protection is attained
after only two infections. To qualitatively and quantitatively
compare both models and thus highlight the effect of third and
fourth infection we used a variety of methods for examining
serotype and incidence dynamics.
Serotype synchronisation
First we analysed the synchronisation pattern between
serotypes; we chose serotype 1 and 2 but since the dynamics of
each serotype are independent, any pair would give the same
results. We distinguished between three different behaviours: (a)
complete synchronisation, which indicates that after some initial
transient the two serotypes coalesce and remain synchronised for
the remainder of a 1000 year time period, that is, the behaviour
of one serotype exactly matches that of the other; (b) partial
synchronisation, which defines a regime where the serotypes are
not fully synchronised but are locked together for at least one
period of more than 100 years; and (c) desynchronised for all
other cases.
Figure 3a shows the synchronisation pattern of the two models
within the (R0,w)-plane. In both models we notice a general trend
from synchronised (blue squares) to desynchronised (red squares)
behaviour as we increase the level of enhancement, w. R0, on the
other hand, does not seem to have a significant effect on this trend
although we find a tendency in model (i) for some partial
synchronisation (green squares) at low levels of R0 and high levels
of w, which is not the case in model (ii).
Sequential replacement of dominant serotypes
We next looked at the serotype dynamics in terms of the
sequential replacement of a dominant serotype. To quantify
sequential dominance we used the same measure previously
introduced by Recker and colleagues [20], given as:
e~
1
P
XP
i~1
Yimax{Y
i
sub
Y imax
,
where P=number of epidemic peaks observed in a certain time
interval considered (here 1000 years), Ymax = the prevalence of the
peaking dominant serotype and Ysub = the prevalence of the
serotype with the second-highest peak. That is, we analysed the
epidemic peaks over a certain time period (here 1000 years) and
examined whether and to what degree these epidemics consisted of
Figure 3. Comparison of synchronisation and single-serotype dominance between model (i) (top) and model (ii) (bottom). (a) The
synchronisation pattern between serotypes 1 and 2 indicates that, for both models, most of parameter space is characterised by desynchronised
behaviour i.e. the dynamics of the two serotypes are not ‘locked’ together. (b) Using a measure of single serotype dominance (where 0 corresponds
to at least two serotypes being simultaneously dominant and higher values indicate a greater tendency for one serotype to be dominating at any
given time), one can observe that in both models the trend is for increasing levels of dominance with increasing enhancement; this trend is more
pronounced in model (ii) than model (i).
doi:10.1371/journal.pone.0012347.g003
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one or more dengue serotypes, which we averaged across all
epidemics within that period. Figure 3b plots e dependent on the
level of transmissibility enhancement, w, and R0. From our
definition e~0 (dark blue in Figure 3b) corresponds to at least two
strains always being simultaneously dominant, and e~1 (dark red
in Figure 3b) indicates that every epidemic consists of just a single
dominant serotype.
Figure 3b demonstrates that in both cases there is a trend of
increasing dominance by and thus replacement of a single serotype
with increasing levels of enhancement, w, and only a small increase
with R0. Importantly, this trend is substantially more pronounced
when allowing for third and fourth infection in model (ii). That is,
sequential replacement of temporary dominant serotypes, which
seems characteristic of dengue epidemiology, can be achieved
through much smaller levels of enhancement if four infections are
required to reach full immunity.
Inter-epidemic period
We next used standard spectral analysis of the total dengue
prevalence to determine the inter-epidemic period under changes
in the reproductive number and level of enhancement. Figure 4a
plots this period within the (R0,w)-plane where a blue colouring
corresponds to short epidemic cycles of roughly 2 years duration
and the transition of the colouring towards red corresponds to a
lengthening of the inter-epidemic period. These long periods of
low prevalence can generally be interpreted as the result of big
epidemic outbreaks that leave the majority of the population
immune and require sufficient time for new susceptible to enter the
population (usually through birth). Both models readily exhibit the
characteristic 3–5 year epidemic cycles of disease incidence
associated with dengue for a reasonably wide range of enhance-
ment, w. Notably, however, the cycles are generally longer and
increase more quickly with increasing levels of enhancement when
third and fourth infections are taken into consideration compared
to model (i) where immunity is already gained after two infections.
We also observe a trend towards longer cycles at high-w, low-R0;
again, this tendency is much less pronounced in model (i). The
eventual consequences are cycles in model (ii) that are practically
twice as long as those observed in model (i). Indeed, it is very rare
in model (i) to observe an inter-epidemic period of longer than 6–7
years whereas in model (ii) a significant region of parameter space
is characterised by periods fn the order of 12 years or more.
Serotype persistence
It has previously been shown that high levels of enhancement
increase the risk of serotype extinction due to large epidemic
outbreaks leading to extended periods of low transmission [6]. In
line with previous work we measured persistence as the proportion
of time a particular serotype persists above a given threshold level
of 1E-8 [6,9]. Figure 4b shows that in both models and for low
levels of enhancement there is only a marginal risk of stochastic
extinction. Nevertheless, and in agreement with previous studies,
high levels of enhancement significantly increases this risk of
extinction and much more so when allowing for third and fourth
infections in model (ii) due to its higher propensity of exhibiting
large amplitude oscillations.
Figure 4. Comparison of inter-epidemic period and serotype persistence between model (i) (top) and model (ii) (bottom). (a) As
enhancement increases so too does the epidemic period observed in each model. There is also a trend towards longer periods at lower R0. However,
these trends both appear to be stronger in model (ii). (b) The risk of stochastic extinction within the model is shown as the proportion of time in each
model that the prevalence of a particular serotype exists above a specific threshold. In both models there is a low risk of extinction but the risk
increases with enhancement; again, this trend is stronger in model (ii).
doi:10.1371/journal.pone.0012347.g004
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Age structure at equilibrium
The only notable effect of third and fourth infections, so far, has
been an overall higher propensity for desynchronised, large
amplitude oscillations. This, however, can be directly attributed
to an overall higher level of transmission that is achieved and
maintained by a larger proportion of the population susceptible to
infection and onward transmission. We therefore also expect an
effect on age-structured prevalence and incidence rates. To
explicitly compare the age structure of prevalence within each
model we adapted the methods of [21]. We consider in both
models the distinct (unstable) equilibrium solutions where all
strains have equal forces of infection in the case of medium levels
of enhancement (w~2). This equilibrium serves as an approxi-
mation of the mean prevalence of each serotype over a long period
of time. In this case, the proportion of the population that has
experienced exactly ‘i’ different strains is given by Ii. The
probability of acquiring a new infection is then proportionate to
the number of yet un-encountered strains. In this case with four
co-circulating dengue serotypes individuals enter Iiz1 from Ii at a
rate 4{ið Þl^, where l^ is the average per capita force of infection
per strain. The dynamics of this system with respect to time, t, and
age, a, may then be described by the following set of partial
differential equations for i~0::3:
dIiz1
dt
z
dIiz1
da
~ 4{ið Þl^Ii{ 4{i{1ð Þl^Ii,
where the proportion of individuals yet unexposed is given by
I0~1{
P
i
Ii. We can then solve these equations (noting, in this
instance, that the time derivative is zero) to approximate how the
number of infections varies with age in each model. In Figure 5a
we have then plotted this data for each model in order to compare
and contrast age structures. In Figure 5b we have made a minor
adaptation to the models in that we consider the case of just 2 or 3
co-circulating serotypes of dengue. To generate this figure we
repeated the above and show how the age of first infection,
average age of disease and total force of infection changes for each
scenario in both models. Finally, Figure 5c shows how the average
age of first infection changes with increasing R0 in both of our
models.
Figure 5 thus demonstrates that including the possibility of third
and fourth infection results in a higher force of infection
(Figure 5b), which generally exposes hosts to dengue at an earlier
age (see Figure 5c) but also delays the acquisition of full immunity.
As an example, it takes roughly twice as long for 50% of the
population to become completely immune compared to the case
where two infections are sufficient for complete protection.
Consequently, allowing for more than two infections increases
the pool of people able to onwardly transmit dengue, which in turn
explains the observed higher force of infection. We also observe in
model (ii) that the proportion of the population that has
experienced at least one heterologous infection is greater at all
ages, which could translate to an increased risk of DHF/DSS
(Figure 5a). Finally, the increased force of infection due to tertiary
or quaternary infections marks a much higher level of serocon-
version: for example, in model (i), by the age of 10 years, only 30%
have seen two infections and 30% are still completely susceptible,
whereas by the same age in model (ii) around 60% have seen at
least two infections and only 10% remain completely susceptible.
Discussion
We have constructed a framework to examine the effect of third
and subsequent infections on dengue epidemiology. Our results
indicate that the qualitative nature of the behaviour observed in
Figure 5. Comparison of age structured dynamics between model (i) and model (ii). (a) The lines show the proportion of the population at
each age (for model (i) (top) and model (ii) (bottom)) who have suffered one (solid dark blue line), two (solid red), three (solid green), four (solid
magenta) and any (solid black) dengue infections. For model (ii) the proportion of the population that is at risk of disease (defined as having seen 1, 2
or 3 serotypes) is also plotted (dotted black) for comparison to the equivalent in model (i) (solid dark blue). Generally, in model (ii) people are exposed
to dengue at an earlier age, experience heterologous infections younger, and take much longer to become completely immune. (b) For model (i) ((ii)),
the blue (green) bar shows how the average age of disease (DHF), determined as heterologous infection, changes with the number of serotypes
present whilst the small bars show the change in age of first infection. The increase in the total force of infection with the number of serotypes is
shown as dotted lines (model (i): blue, and model (ii): green). (c) For model (i) (blue line) and model (ii) (green line) we observe that increasing R0 acts
to decrease the average age of first infection (here estimated as 1/total force of infection) and that for all levels of R0 this value is significantly lower
when allowing for third and fourth infection (model (ii)). Parameter values: w~2 ((a), (b) and (c)) and R0~2 (a), R0~4 (b).
doi:10.1371/journal.pone.0012347.g005
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models with and without third and fourth infections is predom-
inantly similar – in both models, as we increase the level of
antibody dependent enhancement we see a transition from
synchronised serotype oscillations to their desynchronisation and
an increased tendency towards single serotype dominance and
replacement. We also observe an augmented risk of stochastic
extinction and longer inter-epidemic periods due to large
amplitude epidemic outbreaks that leave the majority of the
population immune. Consequently, we can argue that the
fundamental properties of both systems remain invariant to the
introduction of possible third and fourth infections.
However, there are certain critical quantitative ways in which
the results of the models differ from each other. From our
analysis, markedly different patterns of the age structure of
infections can be observed depending on the number of
subsequent infections allowed (Figure 5). A notable feature of
dengue is that it can reach very high seroprevalence rates at a
relatively early age. For example, a study of 210 6–13 year olds in
Haiti revealed that 98% of the cohort had been previously
exposed to dengue [15]; similarly, a study of 4–16 year old
Nicaraguans found an overall seroprevalence of 91%, with 80%
of the children exposed by age 5 [22]. Our results show that in
order to obtain seroprevalence rates which are in line with
epidemiological data one has to assume values of the basic
reproductive number, R0, that are very much higher in a ‘twice
infected - protected’ framework than if allowing the possibility of
a third or fourth infection (Figure 5c). This is because relaxing the
assumption that two heterologous infections are sufficient to
achieve protection from further challenges leads to an overall
higher force of infection, which in turn causes a significant drop
in the age of first infection and thus higher levels of
seroprevalence across all ages (Figure 5a).
Estimates of the basic reproductive number range from R0v2
to R0w11, depending on location and the methods used (see e.g.
[11,23–26]). However, there are a number of reasons to believe
why high values of R0 are unlikely for dengue. Many other vector
borne pathogens have evolved sophisticated immune evasion
mechanisms to prolong their infectious period to overcome the
uncertainty in transmission and vector abundance; dengue, by
contrast, has a relatively short period of infection [27].
Furthermore, the average lifespan and dispersal pattern of its
principle vector, A. aegypti, are limited [28,29], which further
reduces the likelihood of sustained transmission but on the other
hand necessitates a continuous and large pool of susceptible
individuals. Therefore, tertiary and quaternary infections might be
critical for reconciling the features of dengue transmission with the
observed high levels of transmission and consequently high
seroprevalence rates in young children.
As a corollary to the above, increasing the number of co-
circulating serotypes has a much greater effect on both the force of
infection and age of first infection when allowing for tertiary and
quaternary infections. As shown in Figure 5b, and in line with
previous work [30], the overall risk of infection in this case
increases linearly with the number of serotypes whereas the
average age at first infection declines in inverse proportion. By
contrast, increasing the number of serotypes has a negligible effect
on overall force of infection when assuming full protection after
two infections only.
Another important aspect of dengue transmission and R0 which
we have not considered in this work is the effect of spatial
heterogeneity and the role of human movement (see e.g. [31,32]).
Although our results are based on simple mass-action principles
(i.e. random mixing between individuals) we expect the same to
hold true when considering explicit spatial or contact structures. In
fact, the possible constraints on dengue transmission imposed by
spatial structure should benefit from high levels of third and
subsequent infections.
Increasing the number of possible infections and thus the pool of
susceptibles also acts to decrease the average age of clinical disease
through heterologous re-infections; however, this drop could be
partially compensated for by the possibility of developing DHF/
DSS also at third and fourth infection. This means that a low age
of seroconversion and a high age of DHF/DSS are easier to
reconcile if we relax the assumption of clinical protection after
secondary infection. The average age of presentation with DHF
has seen a steady increase over the last few decades in some parts
of SE Asia [33,34], possibly in response to reduction in
transmission through vector control programs [11] or as a
consequence of demographic transitions [35]. Our analysis would
imply that this is less likely to correlate with an overall drop in
seroprevalence if complete cross-protection takes more than two
infections to be established.
The two models analysed in this work represent the two extreme
ends of a cross-immunity spectrum where at one end two
infections are sufficient to protect from further infections and on
the other hand where all four serotypes have to be experienced
and, importantly, where third and fourth infections are enhanced
by pre-existing, cross-reactive antibodies. One can equally imagine
the scenario where only secondary infections are enhanced and/or
subsequent infections contribute less to dengue transmission
through reduced levels of viraemia. However, from our analysis
it is clear that in each scenario there will be a direct relationship
between the overall level of transmission, force of infection and the
resulting age patterns in seroprevalence and incidence of clinical
disease.
In conclusion, our results demonstrate that whether or not
a ‘twice infected - protected’ hypothesis is a realistic and
appropriate description of the full system cannot be determined
from the observed epidemiology of dengue and its four serotypes
alone. However, allowing more than two infections has a
significant impact on the overall force of infection of dengue
and could be a more parsimonious explanation for the observed
epidemiology than inducing high transmission rates. Crucially
also, the fact that low values of R0 are perfectly compatible with
high seroconversion rates is an important consideration for
possible future vaccine strategies. On the other hand, though, if
third and fourth infections do have a significant contribution to
the overall level of dengue transmission, any control strategies
based on drug treatment of clinical cases alone can only be
expected to have a minor effect. More data on the possibility and
transmissibility of tertiary and subsequent infections is therefore
of major importance.
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